Patient Guide: A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 112 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05139017
Status: 🟢 Enrolling Now
Condition: DLBCL, Diffuse Large B-Cell Lymphoma
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 112 locations across the country.

Top locations include:
  • • Walnut Creek, California
  • • Whittier, California
  • • Boca Raton, Florida
  • • And 109 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) - Join Clinical Trial NCTNCT05139017

How to Join This Clinical Trial - NCTNCT05139017

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for DLBCL, Diffuse Large B-Cell Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with DLBCL, Diffuse Large B-Cell Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
DLBCL, Diffuse Large B-Cell Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05139017 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 112 locations. Find a study site near you:

Clinical Research Site

Walnut Creek, California 94598 - United States

Status: RECRUITING

Clinical Research Site

Whittier, California 90603 - United States

Status: COMPLETED

Clinical Research Site

Boca Raton, Florida 33486 - United States

Status: RECRUITING

Clinical Research Site

Clermont, Florida 34711 - United States

Status: RECRUITING

Clinical Research Site

Edgewood, Kentucky 41017 - United States

Status: RECRUITING

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: RECRUITING

Clinical Research Site

New Orleans, Louisiana 70112 - United States

Status: COMPLETED

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: RECRUITING

And 102 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for DLBCL, Diffuse Large B-Cell Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships